Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Company research

Neumora Therapeutics, Inc.

CIK 1885522Updated Nov 2, 2026

NMRA price & chart

Provider market data

Loading TradingView…

NASDAQ:NMRA on TradingView ↗

TradingView · Data may be delayed

About the company

Neumora Therapeutics, Inc. is a clinical-stage biopharmaceutical company founded to confront the greatest medical challenges of our generation by taking a fundamentally different approach to the way treatments for brain diseases are developed. Our therapeutic pipeline currently consists of programs that target novel mechanisms of action for a broad range of underserved, prevalent diseases. Neumora’s mission is to redefine neuroscience drug development by bringing forward the next generation of novel therapies that offer improved treatment outcomes and quality of life for patients.

8-K · 2026-11-16 · 0001193125-26-462165

Company description from the cited filing.

In the news

Seeking Alpha

Financials

FY 2025 · USD
Revenue— · FY 2025
Net income-236,928,000USD · FY 2025
Source

10-K · 2026-03-30 · 0001193125-26-130388

2025-01-01 to 2025-12-31

Operating income-241,156,000USD · FY 2025
Source

10-K · 2026-03-30 · 0001193125-26-130388

2025-01-01 to 2025-12-31

Diluted EPS-1.45USD per share · FY 2025
Source

10-K · 2026-03-30 · 0001193125-26-130388

2025-01-01 to 2025-12-31

Some figures are unavailable for this reporting year.

balance sheet · annual statements
Line itemQ3 2025Q3 2024Q2 2026Q2 2025Q2 2024Q1 2026Q1 2025Q1 2024FY 2025FY 2024FY 2023FY 2022
ASSETS
AssetsUSD177,833,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

As of 2025-09-30

352,537,000
Source

10-Q · 2024-11-12 · 0000950170-24-125437

As of 2024-09-30

125,249,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

As of 2026-06-30

223,825,000
Source

10-Q · 2025-08-06 · 0000950170-25-104138

As of 2025-06-30

404,473,000
Source

10-Q · 2024-08-06 · 0000950170-24-091737

As of 2024-06-30

153,877,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

As of 2026-03-31

256,748,000
Source

10-Q · 2025-05-12 · 0000950170-25-069311

As of 2025-03-31

450,211,000
Source

10-Q · 2024-05-07 · 0000950170-24-054448

As of 2024-03-31

191,047,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

As of 2025-12-31

316,972,000
Source

10-K · 2025-03-03 · 0000950170-25-030401

As of 2024-12-31

496,195,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

As of 2023-12-31

426,234,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

As of 2022-12-31

Property, Plant and Equipment, NetUSD80,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

As of 2025-09-30

1,297,000
Source

10-Q · 2024-11-12 · 0000950170-24-125437

As of 2024-09-30

25,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

As of 2026-06-30

87,000
Source

10-Q · 2025-08-06 · 0000950170-25-104138

As of 2025-06-30

1,476,000
Source

10-Q · 2024-08-06 · 0000950170-24-091737

As of 2024-06-30

32,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

As of 2026-03-31

982,000
Source

10-Q · 2025-05-12 · 0000950170-25-069311

As of 2025-03-31

1,635,000
Source

10-Q · 2024-05-07 · 0000950170-24-054448

As of 2024-03-31

40,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

As of 2025-12-31

1,140,000
Source

10-K · 2025-03-03 · 0000950170-25-030401

As of 2024-12-31

1,790,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

As of 2023-12-31

2,411,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

As of 2022-12-31

Current assets:
Cash and Cash Equivalents, at Carrying ValueUSD129,071,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

As of 2025-09-30

275,714,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

As of 2024-09-30

116,834,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

As of 2026-06-30

124,523,000
Source

10-Q · 2025-08-06 · 0000950170-25-104138

As of 2025-06-30

150,678,000
Source

10-Q · 2025-08-06 · 0000950170-25-104138

As of 2024-06-30

147,072,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

As of 2026-03-31

126,860,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

As of 2025-03-31

182,927,000
Source

10-Q · 2025-05-12 · 0000950170-25-069311

As of 2024-03-31

182,530,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

As of 2025-12-31

142,148,000
Source

10-K · 2025-03-03 · 0000950170-25-030401

As of 2024-12-31

374,038,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

As of 2023-12-31

240,943,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

As of 2022-12-31

Assets, CurrentUSD177,082,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

As of 2025-09-30

348,608,000
Source

10-Q · 2024-11-12 · 0000950170-24-125437

As of 2024-09-30

124,874,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

As of 2026-06-30

222,909,000
Source

10-Q · 2025-08-06 · 0000950170-25-104138

As of 2025-06-30

398,319,000
Source

10-Q · 2024-08-06 · 0000950170-24-091737

As of 2024-06-30

153,434,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

As of 2026-03-31

254,866,000
Source

10-Q · 2025-05-12 · 0000950170-25-069311

As of 2025-03-31

442,785,000
Source

10-Q · 2024-05-07 · 0000950170-24-054448

As of 2024-03-31

190,537,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

As of 2025-12-31

314,055,000
Source

10-K · 2025-03-03 · 0000950170-25-030401

As of 2024-12-31

478,279,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

As of 2023-12-31

387,955,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

As of 2022-12-31

Prepaid Expense and Other Assets, CurrentUSD5,557,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

As of 2025-09-30

6,088,000
Source

10-Q · 2024-11-12 · 0000950170-24-125437

As of 2024-09-30

8,040,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

As of 2026-06-30

5,321,000
Source

10-Q · 2025-08-06 · 0000950170-25-104138

As of 2025-06-30

26,680,000
Source

10-Q · 2024-08-06 · 0000950170-24-091737

As of 2024-06-30

6,362,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

As of 2026-03-31

4,300,000
Source

10-Q · 2025-05-12 · 0000950170-25-069311

As of 2025-03-31

20,070,000
Source

10-Q · 2024-05-07 · 0000950170-24-054448

As of 2024-03-31

8,007,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

As of 2025-12-31

5,264,000
Source

10-K · 2025-03-03 · 0000950170-25-030401

As of 2024-12-31

24,297,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

As of 2023-12-31

16,021,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

As of 2022-12-31

Operating Lease, Right-of-Use AssetUSD474,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

As of 2025-09-30

2,632,000
Source

10-Q · 2024-11-12 · 0000950170-24-125437

As of 2024-09-30

297,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

As of 2026-06-30

531,000
Source

10-Q · 2025-08-06 · 0000950170-25-104138

As of 2025-06-30

3,465,000
Source

10-Q · 2024-08-06 · 0000950170-24-091737

As of 2024-06-30

358,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

As of 2026-03-31

900,000
Source

10-Q · 2025-05-12 · 0000950170-25-069311

As of 2025-03-31

4,276,000
Source

10-Q · 2024-05-07 · 0000950170-24-054448

As of 2024-03-31

417,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

As of 2025-12-31

1,777,000
Source

10-K · 2025-03-03 · 0000950170-25-030401

As of 2024-12-31

5,068,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

As of 2023-12-31

8,231,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

As of 2022-12-31

Other Assets, NoncurrentUSD197,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

As of 2025-09-30

—53,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

As of 2026-06-30

298,000
Source

10-Q · 2025-08-06 · 0000950170-25-104138

As of 2025-06-30

—53,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

As of 2026-03-31

——53,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

As of 2025-12-31

——2,913,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

As of 2022-12-31

LIABILITIES AND EQUITY
LiabilitiesUSD45,672,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

As of 2025-09-30

31,798,000
Source

10-Q · 2024-11-12 · 0000950170-24-125437

As of 2024-09-30

80,730,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

As of 2026-06-30

40,946,000
Source

10-Q · 2025-08-06 · 0000950170-25-104138

As of 2025-06-30

23,214,000
Source

10-Q · 2024-08-06 · 0000950170-24-091737

As of 2024-06-30

83,197,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

As of 2026-03-31

28,384,000
Source

10-Q · 2025-05-12 · 0000950170-25-069311

As of 2025-03-31

25,669,000
Source

10-Q · 2024-05-07 · 0000950170-24-054448

As of 2024-03-31

87,176,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

As of 2025-12-31

29,908,000
Source

10-K · 2025-03-03 · 0000950170-25-030401

As of 2024-12-31

27,119,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

As of 2023-12-31

29,397,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

As of 2022-12-31

Stockholders’ equity:
Preferred Stock, Value, IssuedUSD——————————0
Source

10-K · 2024-03-07 · 0000950170-24-027927

As of 2023-12-31

—
Common Stock, Value, IssuedUSD16,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

As of 2025-09-30

16,000
Source

10-Q · 2024-11-12 · 0000950170-24-125437

As of 2024-09-30

19,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

As of 2026-06-30

16,000
Source

10-Q · 2025-08-06 · 0000950170-25-104138

As of 2025-06-30

16,000
Source

10-Q · 2024-08-06 · 0000950170-24-091737

As of 2024-06-30

18,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

As of 2026-03-31

16,000
Source

10-Q · 2025-05-12 · 0000950170-25-069311

As of 2025-03-31

16,000
Source

10-Q · 2024-05-07 · 0000950170-24-054448

As of 2024-03-31

17,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

As of 2025-12-31

16,000
Source

10-K · 2025-03-03 · 0000950170-25-030401

As of 2024-12-31

16,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

As of 2023-12-31

3,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

As of 2022-12-31

Retained Earnings (Accumulated Deficit)USD-1,124,699,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

As of 2025-09-30

-888,402,000
Source

10-Q · 2024-11-12 · 0000950170-24-125437

As of 2024-09-30

-1,280,689,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

As of 2026-06-30

-1,067,944,000
Source

10-Q · 2025-08-06 · 0000950170-25-104138

As of 2025-06-30

-815,855,000
Source

10-Q · 2024-08-06 · 0000950170-24-091737

As of 2024-06-30

-1,237,607,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

As of 2026-03-31

-1,015,213,000
Source

10-Q · 2025-05-12 · 0000950170-25-069311

As of 2025-03-31

-757,155,000
Source

10-Q · 2024-05-07 · 0000950170-24-054448

As of 2024-03-31

-1,184,149,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

As of 2025-12-31

-947,221,000
Source

10-K · 2025-03-03 · 0000950170-25-030401

As of 2024-12-31

-703,434,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

As of 2023-12-31

-467,509,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

As of 2022-12-31

Accumulated Other Comprehensive Income (Loss), Net of TaxUSD9,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

As of 2025-09-30

105,000
Source

10-Q · 2024-11-12 · 0000950170-24-125437

As of 2024-09-30

—-15,000
Source

10-Q · 2025-08-06 · 0000950170-25-104138

As of 2025-06-30

-187,000
Source

10-Q · 2024-08-06 · 0000950170-24-091737

As of 2024-06-30

—-3,000
Source

10-Q · 2025-05-12 · 0000950170-25-069311

As of 2025-03-31

-148,000
Source

10-Q · 2024-05-07 · 0000950170-24-054448

As of 2024-03-31

—62,000
Source

10-K · 2025-03-03 · 0000950170-25-030401

As of 2024-12-31

-76,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

As of 2023-12-31

-774,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

As of 2022-12-31

Stockholders' Equity Attributable to ParentUSD132,161,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

As of 2025-09-30

320,739,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

As of 2024-09-30

44,519,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

As of 2026-06-30

182,879,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

As of 2025-06-30

381,259,000
Source

10-Q · 2025-08-06 · 0000950170-25-104138

As of 2024-06-30

70,680,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

As of 2026-03-31

228,364,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

As of 2025-03-31

424,542,000
Source

10-Q · 2025-05-12 · 0000950170-25-069311

As of 2024-03-31

103,871,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

As of 2025-12-31

287,064,000
Source

10-K · 2025-03-03 · 0000950170-25-030401

As of 2024-12-31

469,076,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

As of 2023-12-31

-446,850,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

As of 2022-12-31

Additional Paid in Capital, Common StockUSD1,256,835,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

As of 2025-09-30

1,209,020,000
Source

10-Q · 2024-11-12 · 0000950170-24-125437

As of 2024-09-30

1,325,189,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

As of 2026-06-30

1,250,822,000
Source

10-Q · 2025-08-06 · 0000950170-25-104138

As of 2025-06-30

1,197,285,000
Source

10-Q · 2024-08-06 · 0000950170-24-091737

As of 2024-06-30

1,308,269,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

As of 2026-03-31

1,243,564,000
Source

10-Q · 2025-05-12 · 0000950170-25-069311

As of 2025-03-31

1,181,829,000
Source

10-Q · 2024-05-07 · 0000950170-24-054448

As of 2024-03-31

1,288,003,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

As of 2025-12-31

1,234,207,000
Source

10-K · 2025-03-03 · 0000950170-25-030401

As of 2024-12-31

1,172,570,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

As of 2023-12-31

21,430,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

As of 2022-12-31

Liabilities and EquityUSD177,833,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

As of 2025-09-30

352,537,000
Source

10-Q · 2024-11-12 · 0000950170-24-125437

As of 2024-09-30

125,249,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

As of 2026-06-30

223,825,000
Source

10-Q · 2025-08-06 · 0000950170-25-104138

As of 2025-06-30

404,473,000
Source

10-Q · 2024-08-06 · 0000950170-24-091737

As of 2024-06-30

153,877,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

As of 2026-03-31

256,748,000
Source

10-Q · 2025-05-12 · 0000950170-25-069311

As of 2025-03-31

450,211,000
Source

10-Q · 2024-05-07 · 0000950170-24-054448

As of 2024-03-31

191,047,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

As of 2025-12-31

316,972,000
Source

10-K · 2025-03-03 · 0000950170-25-030401

As of 2024-12-31

496,195,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

As of 2023-12-31

426,234,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

As of 2022-12-31

Current liabilities:
Liabilities, CurrentUSD25,842,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

As of 2025-09-30

31,743,000
Source

10-Q · 2024-11-12 · 0000950170-24-125437

As of 2024-09-30

27,777,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

As of 2026-06-30

21,156,000
Source

10-Q · 2025-08-06 · 0000950170-25-104138

As of 2025-06-30

23,125,000
Source

10-Q · 2024-08-06 · 0000950170-24-091737

As of 2024-06-30

30,115,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

As of 2026-03-31

28,384,000
Source

10-Q · 2025-05-12 · 0000950170-25-069311

As of 2025-03-31

24,609,000
Source

10-Q · 2024-05-07 · 0000950170-24-054448

As of 2024-03-31

32,451,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

As of 2025-12-31

29,886,000
Source

10-K · 2025-03-03 · 0000950170-25-030401

As of 2024-12-31

25,111,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

As of 2023-12-31

23,697,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

As of 2022-12-31

Operating Lease, Liability, CurrentUSD256,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

As of 2025-09-30

2,745,000
Source

10-Q · 2024-11-12 · 0000950170-24-125437

As of 2024-09-30

299,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

As of 2026-06-30

171,000
Source

10-Q · 2025-08-06 · 0000950170-25-104138

As of 2025-06-30

3,607,000
Source

10-Q · 2024-08-06 · 0000950170-24-091737

As of 2024-06-30

291,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

As of 2026-03-31

938,000
Source

10-Q · 2025-05-12 · 0000950170-25-069311

As of 2025-03-31

3,491,000
Source

10-Q · 2024-05-07 · 0000950170-24-054448

As of 2024-03-31

284,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

As of 2025-12-31

1,853,000
Source

10-K · 2025-03-03 · 0000950170-25-030401

As of 2024-12-31

3,378,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

As of 2023-12-31

3,370,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

As of 2022-12-31

Accounts Payable, CurrentUSD549,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

As of 2025-09-30

6,107,000
Source

10-Q · 2024-11-12 · 0000950170-24-125437

As of 2024-09-30

4,147,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

As of 2026-06-30

644,000
Source

10-Q · 2025-08-06 · 0000950170-25-104138

As of 2025-06-30

1,082,000
Source

10-Q · 2024-08-06 · 0000950170-24-091737

As of 2024-06-30

5,057,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

As of 2026-03-31

1,052,000
Source

10-Q · 2025-05-12 · 0000950170-25-069311

As of 2025-03-31

1,492,000
Source

10-Q · 2024-05-07 · 0000950170-24-054448

As of 2024-03-31

3,379,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

As of 2025-12-31

3,307,000
Source

10-K · 2025-03-03 · 0000950170-25-030401

As of 2024-12-31

337,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

As of 2023-12-31

7,147,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

As of 2022-12-31

Operating Lease, Liability, NoncurrentUSD267,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

As of 2025-09-30

—41,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

As of 2026-06-30

339,000
Source

10-Q · 2025-08-06 · 0000950170-25-104138

As of 2025-06-30

—119,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

As of 2026-03-31

—938,000
Source

10-Q · 2024-05-07 · 0000950170-24-054448

As of 2024-03-31

193,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

As of 2025-12-31

—1,853,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

As of 2023-12-31

5,072,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

As of 2022-12-31

Additional Financial Items
Accrued Liabilities, CurrentUSD24,982,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

As of 2025-09-30

22,758,000
Source

10-Q · 2024-11-12 · 0000950170-24-125437

As of 2024-09-30

23,331,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

As of 2026-06-30

20,253,000
Source

10-Q · 2025-08-06 · 0000950170-25-104138

As of 2025-06-30

18,303,000
Source

10-Q · 2024-08-06 · 0000950170-24-091737

As of 2024-06-30

24,767,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

As of 2026-03-31

26,272,000
Source

10-Q · 2025-05-12 · 0000950170-25-069311

As of 2025-03-31

19,493,000
Source

10-Q · 2024-05-07 · 0000950170-24-054448

As of 2024-03-31

28,788,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

As of 2025-12-31

24,593,000
Source

10-K · 2025-03-03 · 0000950170-25-030401

As of 2024-12-31

21,257,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

As of 2023-12-31

11,536,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

As of 2022-12-31

Long-term Debt, Excluding Current MaturitiesUSD19,563,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

As of 2025-09-30

—52,912,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

As of 2026-06-30

19,451,000
Source

10-Q · 2025-08-06 · 0000950170-25-104138

As of 2025-06-30

—52,963,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

As of 2026-03-31

——54,532,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

As of 2025-12-31

———
Long-term Debt, Current MaturitiesUSD20,000,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

As of 2025-09-30

—60,000,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

As of 2026-06-30

20,000,000
Source

10-Q · 2025-08-06 · 0000950170-25-104138

As of 2025-06-30

—60,000,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

As of 2026-03-31

——60,000,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

As of 2025-12-31

———
Long-term Debt, Excluding Current MaturitiesUSD19,563,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

As of 2025-09-30

—52,912,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

As of 2026-06-30

19,451,000
Source

10-Q · 2025-08-06 · 0000950170-25-104138

As of 2025-06-30

—52,963,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

As of 2026-03-31

——54,532,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

As of 2025-12-31

———

Lines labelled “Derived” are calculated from reported figures.

cash flow · annual statements
Line itemQ4 2025Q4 2024Q3 2025Q3 2024Q2 2026Q2 2025Q1 2026Q1 2025FY 2025FY 2024FY 2023FY 2022
Cash flows from operating activities:
Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD——————-53,458,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2026-01-01 to 2026-03-31

-67,992,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2025-01-01 to 2025-03-31

-236,928,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

2025-01-01 to 2025-12-31

-243,787,000
Source

10-K · 2025-03-03 · 0000950170-25-030401

2024-01-01 to 2024-12-31

-235,925,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2023-01-01 to 2023-12-31

-130,904,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2022-01-01 to 2022-12-31

Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, Depletion and AmortizationUSD——————8,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2026-01-01 to 2026-03-31

157,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2025-01-01 to 2025-03-31

208,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

2025-01-01 to 2025-12-31

631,000
Source

10-K · 2025-03-03 · 0000950170-25-030401

2024-01-01 to 2024-12-31

668,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2023-01-01 to 2023-12-31

594,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2022-01-01 to 2022-12-31

Share-based Payment Arrangement, Noncash ExpenseUSD——————7,405,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2026-01-01 to 2026-03-31

9,324,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2025-01-01 to 2025-03-31

29,876,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

2025-01-01 to 2025-12-31

39,990,000
Source

10-K · 2025-03-03 · 0000950170-25-030401

2024-01-01 to 2024-12-31

17,240,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2023-01-01 to 2023-12-31

8,298,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2022-01-01 to 2022-12-31

Changes in operating assets and liabilities:
Increase (Decrease) in Accounts PayableUSD——————1,678,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2026-01-01 to 2026-03-31

-2,255,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2025-01-01 to 2025-03-31

71,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

2025-01-01 to 2025-12-31

2,873,000
Source

10-K · 2025-03-03 · 0000950170-25-030401

2024-01-01 to 2024-12-31

-581,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2023-01-01 to 2023-12-31

-1,246,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2022-01-01 to 2022-12-31

Net Cash Provided by (Used in) Operating ActivitiesUSD——————-46,404,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2026-01-01 to 2026-03-31

-59,448,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2025-01-01 to 2025-03-31

-206,440,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

2025-01-01 to 2025-12-31

-182,936,000
Source

10-K · 2025-03-03 · 0000950170-25-030401

2024-01-01 to 2024-12-31

-163,278,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2023-01-01 to 2023-12-31

-114,896,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2022-01-01 to 2022-12-31

Cash flows from investing activities:
Net Cash Provided by (Used in) Investing ActivitiesUSD——————71,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2026-01-01 to 2026-03-31

44,160,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2025-01-01 to 2025-03-31

168,520,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

2025-01-01 to 2025-12-31

-70,557,000
Source

10-K · 2025-03-03 · 0000950170-25-030401

2024-01-01 to 2024-12-31

64,387,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2023-01-01 to 2023-12-31

-168,013,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2022-01-01 to 2022-12-31

Payments to Acquire Property, Plant, and EquipmentUSD——————————117,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2023-01-01 to 2023-12-31

511,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2022-01-01 to 2022-12-31

Cash flows from financing activities:
Net Cash Provided by (Used in) Financing ActivitiesUSD——————10,875,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2026-01-01 to 2026-03-31

0
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2025-01-01 to 2025-03-31

77,089,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

2025-01-01 to 2025-12-31

21,603,000
Source

10-K · 2025-03-03 · 0000950170-25-030401

2024-01-01 to 2024-12-31

231,936,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2023-01-01 to 2023-12-31

115,743,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2022-01-01 to 2022-12-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD——————-35,458,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2026-01-01 to 2026-03-31

-15,288,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2025-01-01 to 2025-03-31

39,169,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

2025-01-01 to 2025-12-31

-231,890,000
Source

10-K · 2025-03-03 · 0000950170-25-030401

2024-01-01 to 2024-12-31

133,045,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2023-01-01 to 2023-12-31

-167,166,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2022-01-01 to 2022-12-31

Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD——747,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

2025-07-01 to 2025-09-30

0
Source

10-Q · 2025-11-06 · 0001193125-25-269446

2024-07-01 to 2024-09-30

1,820,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2026-04-01 to 2026-06-30

436,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2025-04-01 to 2025-06-30

1,854,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2026-01-01 to 2026-03-31

—3,219,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

2025-01-01 to 2025-12-31

———
Income Taxes Paid, NetUSD——————30,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2026-01-01 to 2026-03-31

0
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2025-01-01 to 2025-03-31

323,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

2025-01-01 to 2025-12-31

473,000
Source

10-K · 2025-03-03 · 0000950170-25-030401

2024-01-01 to 2024-12-31

——
Additional Financial Items
Accretion ExpenseUSD————261,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2026-04-01 to 2026-06-30

43,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2025-04-01 to 2025-06-30

287,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2026-01-01 to 2026-03-31

—336,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

2025-01-01 to 2025-12-31

———
Share-based Payment Arrangement, ExpenseUSD——5,980,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

2025-07-01 to 2025-09-30

9,946,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

2024-07-01 to 2024-09-30

7,184,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2026-04-01 to 2026-06-30

7,165,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2025-04-01 to 2025-06-30

7,405,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2026-01-01 to 2026-03-31

9,324,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2025-01-01 to 2025-03-31

29,876,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

2025-01-01 to 2025-12-31

39,990,000
Source

10-K · 2025-03-03 · 0000950170-25-030401

2024-01-01 to 2024-12-31

17,240,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2023-01-01 to 2023-12-31

8,298,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2022-01-01 to 2022-12-31

Amortization of Debt Issuance CostsUSD————0
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2026-04-01 to 2026-06-30

67,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2025-04-01 to 2025-06-30

——270,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

2025-01-01 to 2025-12-31

———
Amortization of Debt Issuance Costs and DiscountsUSD————133,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2026-04-01 to 2026-06-30

19,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2025-04-01 to 2025-06-30

131,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2026-01-01 to 2026-03-31

—156,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

2025-01-01 to 2025-12-31

———
DepreciationUSD————————200,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

2025-01-01 to 2025-12-31

———
Gain (Loss) on InvestmentsUSD———————————18,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2022-01-01 to 2022-12-31

Gain (Loss) on Disposition of Property Plant EquipmentUSD——————71,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2026-01-01 to 2026-03-31

0
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2025-01-01 to 2025-03-31

-47,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

2025-01-01 to 2025-12-31

———
General and Administrative ExpenseUSD——12,180,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

2025-07-01 to 2025-09-30

16,016,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

2024-07-01 to 2024-09-30

12,907,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2026-04-01 to 2026-06-30

15,316,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2025-04-01 to 2025-06-30

14,266,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2026-01-01 to 2026-03-31

18,785,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2025-01-01 to 2025-03-31

60,091,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

2025-01-01 to 2025-12-31

62,537,000
Source

10-K · 2025-03-03 · 0000950170-25-030401

2024-01-01 to 2024-12-31

45,475,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2023-01-01 to 2023-12-31

31,121,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2022-01-01 to 2022-12-31

Income Tax Expense (Benefit)USD——0
Source

10-Q · 2025-11-06 · 0001193125-25-269446

2025-07-01 to 2025-09-30

53,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

2024-07-01 to 2024-09-30

0
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2026-04-01 to 2026-06-30

25,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2025-04-01 to 2025-06-30

30,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2026-01-01 to 2026-03-31

105,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2025-01-01 to 2025-03-31

130,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

2025-01-01 to 2025-12-31

178,000
Source

10-K · 2025-03-03 · 0000950170-25-030401

2024-01-01 to 2024-12-31

268,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2023-01-01 to 2023-12-31

—
InterestExpenseNonoperatingUSD——747,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

2025-07-01 to 2025-09-30

0
Source

10-Q · 2025-11-06 · 0001193125-25-269446

2024-07-01 to 2024-09-30

1,820,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2026-04-01 to 2026-06-30

436,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2025-04-01 to 2025-06-30

1,854,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2026-01-01 to 2026-03-31

0
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2025-01-01 to 2025-03-31

3,219,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

2025-01-01 to 2025-12-31

———
Investment Income, InterestUSD——1,685,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

2025-07-01 to 2025-09-30

4,209,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

2024-07-01 to 2024-09-30

935,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2026-04-01 to 2026-06-30

2,250,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2025-04-01 to 2025-06-30

1,231,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2026-01-01 to 2026-03-31

3,074,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2025-01-01 to 2025-03-31

8,344,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

2025-01-01 to 2025-12-31

———
Net Income (Loss) Attributable to ParentUSD——-56,755,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

2025-07-01 to 2025-09-30

-72,547,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

2024-07-01 to 2024-09-30

-43,082,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2026-04-01 to 2026-06-30

-52,731,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2025-04-01 to 2025-06-30

-53,458,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2026-01-01 to 2026-03-31

-67,992,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2025-01-01 to 2025-03-31

-236,928,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

2025-01-01 to 2025-12-31

-243,787,000
Source

10-K · 2025-03-03 · 0000950170-25-030401

2024-01-01 to 2024-12-31

-235,925,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2023-01-01 to 2023-12-31

-130,904,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2022-01-01 to 2022-12-31

Nonoperating Income (Expense)USD——945,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

2025-07-01 to 2025-09-30

4,152,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

2024-07-01 to 2024-09-30

-892,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2026-04-01 to 2026-06-30

1,334,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2025-04-01 to 2025-06-30

-564,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2026-01-01 to 2026-03-31

3,049,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2025-01-01 to 2025-03-31

4,358,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

2025-01-01 to 2025-12-31

19,855,000
Source

10-K · 2025-03-03 · 0000950170-25-030401

2024-01-01 to 2024-12-31

16,441,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2023-01-01 to 2023-12-31

4,966,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2022-01-01 to 2022-12-31

Operating ExpensesUSD——57,700,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

2025-07-01 to 2025-09-30

76,646,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

2024-07-01 to 2024-09-30

42,190,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2026-04-01 to 2026-06-30

54,040,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2025-04-01 to 2025-06-30

52,864,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2026-01-01 to 2026-03-31

70,936,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2025-01-01 to 2025-03-31

241,156,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

2025-01-01 to 2025-12-31

263,464,000
Source

10-K · 2025-03-03 · 0000950170-25-030401

2024-01-01 to 2024-12-31

252,098,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2023-01-01 to 2023-12-31

135,870,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2022-01-01 to 2022-12-31

Other Nonoperating Income (Expense)USD——7,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

2025-07-01 to 2025-09-30

-57,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

2024-07-01 to 2024-09-30

-7,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2026-04-01 to 2026-06-30

-480,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2025-04-01 to 2025-06-30

59,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2026-01-01 to 2026-03-31

-25,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2025-01-01 to 2025-03-31

-767,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

2025-01-01 to 2025-12-31

-78,000
Source

10-K · 2025-03-03 · 0000950170-25-030401

2024-01-01 to 2024-12-31

-170,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2023-01-01 to 2023-12-31

405,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2022-01-01 to 2022-12-31

Proceeds from Issuance of Common StockUSD——————————810,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2023-01-01 to 2023-12-31

—
Proceeds from Stock Options ExercisedUSD———————0
Source

10-Q · 2025-05-12 · 0000950170-25-069311

2025-01-01 to 2025-03-31

0
Source

10-K · 2026-03-30 · 0001193125-26-130388

2025-01-01 to 2025-12-31

7,482,000
Source

10-K · 2025-03-03 · 0000950170-25-030401

2024-01-01 to 2024-12-31

2,856,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2023-01-01 to 2023-12-31

2,658,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2022-01-01 to 2022-12-31

Lines labelled “Derived” are calculated from reported figures.

income statement · annual statements
Line itemQ4 2025Q4 2024Q3 2025Q3 2024Q2 2026Q2 2025Q1 2026Q1 2025FY 2025FY 2024FY 2023FY 2022
Operating Income (Loss)USD——-57,700,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

2025-07-01 to 2025-09-30

-76,646,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

2024-07-01 to 2024-09-30

-42,190,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2026-04-01 to 2026-06-30

-54,040,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2025-04-01 to 2025-06-30

-52,864,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2026-01-01 to 2026-03-31

-70,936,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2025-01-01 to 2025-03-31

-241,156,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

2025-01-01 to 2025-12-31

-263,464,000
Source

10-K · 2025-03-03 · 0000950170-25-030401

2024-01-01 to 2024-12-31

-252,098,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2023-01-01 to 2023-12-31

-135,870,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2022-01-01 to 2022-12-31

Other Nonoperating Income (Expense)USD——7,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

2025-07-01 to 2025-09-30

-57,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

2024-07-01 to 2024-09-30

-7,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2026-04-01 to 2026-06-30

-480,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2025-04-01 to 2025-06-30

59,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2026-01-01 to 2026-03-31

-25,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2025-01-01 to 2025-03-31

-767,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

2025-01-01 to 2025-12-31

-78,000
Source

10-K · 2025-03-03 · 0000950170-25-030401

2024-01-01 to 2024-12-31

-170,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2023-01-01 to 2023-12-31

405,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2022-01-01 to 2022-12-31

Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD——-56,755,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

2025-07-01 to 2025-09-30

-72,494,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

2024-07-01 to 2024-09-30

-43,082,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2026-04-01 to 2026-06-30

-52,706,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2025-04-01 to 2025-06-30

-53,428,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2026-01-01 to 2026-03-31

-67,887,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2025-01-01 to 2025-03-31

-236,798,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

2025-01-01 to 2025-12-31

-243,609,000
Source

10-K · 2025-03-03 · 0000950170-25-030401

2024-01-01 to 2024-12-31

-235,657,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2023-01-01 to 2023-12-31

-130,904,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2022-01-01 to 2022-12-31

Income Tax Expense (Benefit)USD——0
Source

10-Q · 2025-11-06 · 0001193125-25-269446

2025-07-01 to 2025-09-30

53,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

2024-07-01 to 2024-09-30

0
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2026-04-01 to 2026-06-30

25,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2025-04-01 to 2025-06-30

30,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2026-01-01 to 2026-03-31

105,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2025-01-01 to 2025-03-31

130,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

2025-01-01 to 2025-12-31

178,000
Source

10-K · 2025-03-03 · 0000950170-25-030401

2024-01-01 to 2024-12-31

268,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2023-01-01 to 2023-12-31

—
Net Income (Loss) Attributable to ParentUSD——-56,755,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

2025-07-01 to 2025-09-30

-72,547,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

2024-07-01 to 2024-09-30

-43,082,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2026-04-01 to 2026-06-30

-52,731,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2025-04-01 to 2025-06-30

-53,458,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2026-01-01 to 2026-03-31

-67,992,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2025-01-01 to 2025-03-31

-236,928,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

2025-01-01 to 2025-12-31

-243,787,000
Source

10-K · 2025-03-03 · 0000950170-25-030401

2024-01-01 to 2024-12-31

-235,925,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2023-01-01 to 2023-12-31

-130,904,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2022-01-01 to 2022-12-31

Earnings Per Share, BasicUSD per share——-0.35
Source

10-Q · 2025-11-06 · 0001193125-25-269446

2025-07-01 to 2025-09-30

-0.45
Source

10-Q · 2025-11-06 · 0001193125-25-269446

2024-07-01 to 2024-09-30

-0.23
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2026-04-01 to 2026-06-30

-0.33
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2025-04-01 to 2025-06-30

-0.3
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2026-01-01 to 2026-03-31

-0.42
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2025-01-01 to 2025-03-31

-1.45
Source

10-K · 2026-03-30 · 0001193125-26-130388

2025-01-01 to 2025-12-31

-1.53
Source

10-K · 2025-03-03 · 0000950170-25-030401

2024-01-01 to 2024-12-31

-3.63
Source

10-K · 2024-03-07 · 0000950170-24-027927

2023-01-01 to 2023-12-31

-4.81
Source

10-K · 2024-03-07 · 0000950170-24-027927

2022-01-01 to 2022-12-31

Earnings Per Share, DilutedUSD per share——-0.35
Source

10-Q · 2025-11-06 · 0001193125-25-269446

2025-07-01 to 2025-09-30

-0.45
Source

10-Q · 2025-11-06 · 0001193125-25-269446

2024-07-01 to 2024-09-30

-0.23
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2026-04-01 to 2026-06-30

-0.33
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2025-04-01 to 2025-06-30

-0.3
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2026-01-01 to 2026-03-31

-0.42
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2025-01-01 to 2025-03-31

-1.45
Source

10-K · 2026-03-30 · 0001193125-26-130388

2025-01-01 to 2025-12-31

-1.53
Source

10-K · 2025-03-03 · 0000950170-25-030401

2024-01-01 to 2024-12-31

-3.63
Source

10-K · 2024-03-07 · 0000950170-24-027927

2023-01-01 to 2023-12-31

-4.81
Source

10-K · 2024-03-07 · 0000950170-24-027927

2022-01-01 to 2022-12-31

Weighted Average Number of Shares Outstanding, Basicshares——161,838,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

2025-07-01 to 2025-09-30

159,576,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

2024-07-01 to 2024-09-30

185,163,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2026-04-01 to 2026-06-30

161,691,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2025-04-01 to 2025-06-30

179,872,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2026-01-01 to 2026-03-31

161,451,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2025-01-01 to 2025-03-31

163,391,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

2025-01-01 to 2025-12-31

159,377,000
Source

10-K · 2025-03-03 · 0000950170-25-030401

2024-01-01 to 2024-12-31

65,021,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2023-01-01 to 2023-12-31

27,207,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2022-01-01 to 2022-12-31

Weighted Average Number of Shares Outstanding, Dilutedshares——161,838,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

2025-07-01 to 2025-09-30

159,576,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

2024-07-01 to 2024-09-30

185,163,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2026-04-01 to 2026-06-30

161,691,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2025-04-01 to 2025-06-30

179,872,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2026-01-01 to 2026-03-31

161,451,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2025-01-01 to 2025-03-31

163,391,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

2025-01-01 to 2025-12-31

159,377,000
Source

10-K · 2025-03-03 · 0000950170-25-030401

2024-01-01 to 2024-12-31

65,021,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2023-01-01 to 2023-12-31

27,207,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2022-01-01 to 2022-12-31

Interest Expense (non-operating)USD——747,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

2025-07-01 to 2025-09-30

0
Source

10-Q · 2025-11-06 · 0001193125-25-269446

2024-07-01 to 2024-09-30

1,820,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2026-04-01 to 2026-06-30

436,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2025-04-01 to 2025-06-30

1,854,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2026-01-01 to 2026-03-31

0
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2025-01-01 to 2025-03-31

3,219,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

2025-01-01 to 2025-12-31

———
Additional Financial Items
Gain (Loss) on InvestmentsUSD———————————18,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2022-01-01 to 2022-12-31

General and Administrative ExpenseUSD——12,180,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

2025-07-01 to 2025-09-30

16,016,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

2024-07-01 to 2024-09-30

12,907,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2026-04-01 to 2026-06-30

15,316,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2025-04-01 to 2025-06-30

14,266,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2026-01-01 to 2026-03-31

18,785,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2025-01-01 to 2025-03-31

60,091,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

2025-01-01 to 2025-12-31

62,537,000
Source

10-K · 2025-03-03 · 0000950170-25-030401

2024-01-01 to 2024-12-31

45,475,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2023-01-01 to 2023-12-31

31,121,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2022-01-01 to 2022-12-31

Interest ExpenseUSD————1,426,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2026-04-01 to 2026-06-30

307,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2025-04-01 to 2025-06-30

1,436,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2026-01-01 to 2026-03-31

—2,010,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

2025-01-01 to 2025-12-31

———
Interest Expense, DebtUSD————1,820,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2026-04-01 to 2026-06-30

436,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2025-04-01 to 2025-06-30

1,854,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2026-01-01 to 2026-03-31

—3,219,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

2025-01-01 to 2025-12-31

———
Interest Income (Expense), Nonoperating, NetUSD——1,685,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

2025-07-01 to 2025-09-30

4,209,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

2024-07-01 to 2024-09-30

935,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2026-04-01 to 2026-06-30

2,250,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2025-04-01 to 2025-06-30

1,231,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2026-01-01 to 2026-03-31

3,074,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2025-01-01 to 2025-03-31

8,344,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

2025-01-01 to 2025-12-31

19,933,000
Source

10-K · 2025-03-03 · 0000950170-25-030401

2024-01-01 to 2024-12-31

16,611,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2023-01-01 to 2023-12-31

4,561,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2022-01-01 to 2022-12-31

Investment Income, InterestUSD——1,685,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

2025-07-01 to 2025-09-30

4,209,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

2024-07-01 to 2024-09-30

935,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2026-04-01 to 2026-06-30

2,250,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2025-04-01 to 2025-06-30

1,231,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2026-01-01 to 2026-03-31

3,074,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2025-01-01 to 2025-03-31

8,344,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

2025-01-01 to 2025-12-31

———
Nonoperating Income (Expense)USD——945,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

2025-07-01 to 2025-09-30

4,152,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

2024-07-01 to 2024-09-30

-892,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2026-04-01 to 2026-06-30

1,334,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2025-04-01 to 2025-06-30

-564,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2026-01-01 to 2026-03-31

3,049,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2025-01-01 to 2025-03-31

4,358,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

2025-01-01 to 2025-12-31

19,855,000
Source

10-K · 2025-03-03 · 0000950170-25-030401

2024-01-01 to 2024-12-31

16,441,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2023-01-01 to 2023-12-31

4,966,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2022-01-01 to 2022-12-31

Operating ExpensesUSD——57,700,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

2025-07-01 to 2025-09-30

76,646,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

2024-07-01 to 2024-09-30

42,190,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2026-04-01 to 2026-06-30

54,040,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2025-04-01 to 2025-06-30

52,864,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2026-01-01 to 2026-03-31

70,936,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2025-01-01 to 2025-03-31

241,156,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

2025-01-01 to 2025-12-31

263,464,000
Source

10-K · 2025-03-03 · 0000950170-25-030401

2024-01-01 to 2024-12-31

252,098,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2023-01-01 to 2023-12-31

135,870,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2022-01-01 to 2022-12-31

Research and Development ExpenseUSD——40,520,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

2025-07-01 to 2025-09-30

60,630,000
Source

10-Q · 2025-11-06 · 0001193125-25-269446

2024-07-01 to 2024-09-30

29,283,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2026-04-01 to 2026-06-30

38,724,000
Source

10-Q · 2026-08-14 · 0001193125-26-350370

2025-04-01 to 2025-06-30

38,598,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2026-01-01 to 2026-03-31

52,151,000
Source

10-Q · 2026-05-07 · 0001193125-26-211825

2025-01-01 to 2025-03-31

176,065,000
Source

10-K · 2026-03-30 · 0001193125-26-130388

2025-01-01 to 2025-12-31

200,927,000
Source

10-K · 2025-03-03 · 0000950170-25-030401

2024-01-01 to 2024-12-31

142,719,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2023-01-01 to 2023-12-31

91,749,000
Source

10-K · 2024-03-07 · 0000950170-24-027927

2022-01-01 to 2022-12-31

Lines labelled “Derived” are calculated from reported figures.

Filing attachments

nmra-ex99_1.htm · 8-K · 2026-11-16

Exhibit 99.1 Neumora Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update IND application for NMRA-215 (NLRP3 inhibitor) submitted to the U.S. Food and Drug Administration Dose-proportional increase in exposure observed in multiple ascending dose (MAD) expansion cohort with NMRA-511 (V1aR antagonist), suggesting potential to build on the efficacy profile demonstrated in Phase 1b study WATERTOWN, Mass., November 16, 2026 - Neumora Therapeutics, Inc. (Nasdaq: …

8-K · 2026-11-16 · 0001193125-26-462165

Read attachment ↗
nmra-ex99_1.htm · 8-K · 2026-08-14

EX-99.1 2 nmra-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Neumora Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update Favorable pre-clinical data reported for NMRA-215 with plan to submit IND in fourth quarter of 2026 and initiate Phase 1 study by end of 2026 Progressing NMRA-511 in Alzheimer’s disease (AD) agitation and NMRA-898 in schizophrenia with clinical data expected in fourth quarter of 2026 and second half of 2026, respectively Joshua Pinto, Ph.…

8-K · 2026-08-14 · 0001193125-26-350349

Read attachment ↗
nmra-ex99_1.htm · 8-K · 2026-07-27

EX-99.1 2 nmra-ex99_1.htm EX-99.1 EX-99.1 EXHIBIT 99.1 Neumora Therapeutics Reports Favorable NMRA-215 Toxicology Results with Planned Clinical Advancement in 2026 Company plans to submit an IND in the fourth quarter of 2026 and to initiate Phase 1 study by the end of 2026 WATERTOWN, Mass., July 27, 2026 -- Neumora Therapeutics, Inc. (Nasdaq: NMRA) a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of programs that target novel mechanisms of action for a b…

8-K · 2026-07-27 · 0001193125-26-316819

Read attachment ↗
d943192dex991.htm · 8-K · 2026-06-15

EX-99.1 2 d943192dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Neumora Therapeutics Reports Data from Phase 3 KOASTAL Program and Provides Business and Pipeline Update Navacaprant did not achieve the primary endpoint in KOASTAL-2 or -3; Company to discontinue development of navacaprant Advancing potential best-in-class programs with NMRA-511 in Alzheimer’s disease agitation, NMRA-898 in schizophrenia and NMRA-215 in cardiometabolic disease Aligning organization to support initiation of mult…

8-K · 2026-06-15 · 0001193125-26-270328

Read attachment ↗
nmra-ex99_1.htm · 8-K · 2026-05-07

EX-99.1 2 nmra-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Neumora Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update KOASTAL-2 and -3 studies evaluating navacaprant in major depressive disorder on track for joint topline readout in the second quarter of 2026 Progressing NMRA-511 in Alzheimer’s disease agitation and NMRA-898 in schizophrenia with clinical data expected for each program in the second half of 2026 Strong financial position with $147.1 milli…

8-K · 2026-05-07 · 0001193125-26-210310

Read attachment ↗
nmra-ex4_3.htm · 10-K · 2026-03-30

EXHIBIT 4.3 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The following description is a description of the common stock, $0.0001 par value per share, of Neumora Therapeutics, Inc. (the “Company,” “we,” “our,” or “us”) which is the only security of the Company registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). This summary is subject to the General Corporation Law of t…

10-K · 2026-03-30 · 0001193125-26-130388

Read attachment ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.